Analysis of Data Collected From Right and Left Limbs: Accounting for Dependence and Improving Statistical Efficiency in Musculoskeletal Research by Stewart, S et al.
Accepted Manuscript
Title: Analysis of data collected from right and left limbs:
accounting for dependence and improving statistical efficiency
in musculoskeletal research
Authors: Sarah Stewart, Janet Pearson, Keith Rome, Nicola
Dalbeth, Alain C. Vandal
PII: S0966-6362(17)30974-8
DOI: https://doi.org/10.1016/j.gaitpost.2017.10.018
Reference: GAIPOS 5847
To appear in: Gait & Posture
Received date: 9-8-2017
Revised date: 5-10-2017
Accepted date: 13-10-2017
Please cite this article as: Stewart Sarah, Pearson Janet, Rome Keith, Dalbeth Nicola,
Vandal Alain C.Analysis of data collected from right and left limbs: accounting for
dependence and improving statistical efficiency in musculoskeletal research.Gait and
Posture https://doi.org/10.1016/j.gaitpost.2017.10.018
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Analysis of data collected from right and left limbs: accounting for dependence and 
improving statistical efficiency in musculoskeletal research 
 
AUTHORS 
Sarah Stewarta, corresponding author: +64 21 176 7690; sarah.stewart@aut.ac.nz 
Janet Pearsonb, janet.pearson@aut.ac.nz 
Keith Romea, krome@aut.ac.nz 
Nicola Dalbethc, n.dalbeth@auckland.ac.nz 
Alain C. Vandalb,d, alain.vandal@aut.ac.nz 
aDepartment of Podiatry, Health & Rehabilitation Research Institute, Auckland University of 
Technology, Private Bag 92006, Auckland 1142, New Zealand Zealand. 
bDepartment of Biostatistics & Epidemiology, Faculty of Health and Environmental Sciences, 
Auckland University of Technology, Private Bag 92006, Auckland 1142, New Zealand. 
cFaculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, 
Auckland 1142, New Zealand. 
dKo Awatea, Counties Manukau District Health Board, Private Bag 93311, Auckland 1640, 
New Zealand. 
 
Highlights 
 Current statistical methods inefficiently account for paired-limb measurements 
 Multivariate mixed-effects models provide more precise estimates 
 Multivariate mixed-effects models generate results of greater efficiency and power 
 
ABSTRACT 
Objectives. Statistical techniques currently used in musculoskeletal research often 
inefficiently account for paired-limb measurements or the relationship between 
measurements taken from multiple regions within limbs. This study compared three 
commonly used analysis methods with a mixed-models approach that appropriately 
accounted for the association between limbs, regions, and trials and that utilised all 
information available from repeated trials. 
Method. Four analysis methods were applied to an existing data set containing plantar 
pressure data, which was collected for seven masked regions on right and left feet, over three 
trials, across three participant groups. Methods 1-3 averaged data over trials and analysed 
right foot data (Method 1), data from a randomly selected foot (Method 2), and averaged 
right and left foot data (Method 3). Method 4 used all available data in a mixed-effects 
regression that accounted for repeated measures taken for each foot, foot region and trial. 
Confidence interval widths for the mean differences between groups for each foot region 
were used as a criterion for comparison of statistical efficiency. 
Results. Mean differences in pressure between groups were similar across methods for each 
foot region, while the confidence interval widths were consistently smaller for Method 4. 
Method 4 also revealed significant between-group differences that were not detected by 
Methods 1-3. 
Conclusion. A mixed effects linear model approach generates improved efficiency and power 
by producing more precise estimates compared to alternative approaches that discard 
information in the process of accounting for paired-limb measurements. This approach is 
recommended in generating more clinically sound and statistically efficient research outputs. 
KEYWORDS: Plantar pressure; Gait; Statistical analysis; Lower limb; Foot; Mixed effects 
models; Statistical efficiency 
 
INTRODUCTION 
Most rheumatic diseases, including rheumatoid arthritis, gout, osteoarthritis, psoriatic 
arthritis and spondyloarthropathy, present with a variety of musculoskeletal manifestations. 
Gout, osteoarthritis and psoriatic arthritis are often characterised by an asymmetrical pattern 
of distribution with regard to musculoskeletal symptoms, in that right and left limbs are not 
always affected equally. Clinical research in musculoskeletal rheumatology often involves the 
collection of data from right and left limbs from the same participant, resulting in limb-specific 
units of analysis, as opposed to person-specific units of analysis that occur when data are 
collected on single organ systems. However, person-specific and disease-specific factors, 
including age, gender, ethnicity, disease duration and the use of pharmacological therapy, 
result in a high level of within-subject dependence between limbs, meaning that data from 
right and left limbs are often highly correlated [1]. The same is true for multiple 
measurements taken from each limb, including from a range of joints or regions within limbs. 
This becomes problematic in the application of many commonly used statistical procedures, 
including linear models (such as the t-test and analysis of variance) that assume each data 
point is an independent observation [2].  
It is not uncommon for researchers to pool data from right and left sides without accounting 
for the between-side correlation [3, 4]. This approach is often considered a valid method if 
the dependent variables of interest are limb-specific rather than person-specific.  Pooling of 
right and left limb data also provides an appealing option as it apparently doubles the sample 
size while maintaining the same number of participants. However, pooling data results in 
artificial deflation of confidence intervals and significance levels [5, 6] that increases the 
probability of a type I error (rejecting the null hypothesis when it is true) compared to the 
nominal significance level α. 
Several alternative methods have been used in musculoskeletal research to account for 
between-limb dependence, including undertaking a separate analysis of one or both limbs, 
whether this be the right and/or left [7-9], the most dominant side [10], the side with the 
most clinically evident symptoms of disease [11], or a randomly chosen side. However, such 
approaches result in a loss of valuable data and thus a reduction in statistical power and 
precision of estimates, and are overall inefficient methods of analysis. Furthermore, they may 
introduce a bias through the choice of which limb to use, particularly if a non-random 
selection approach is adopted. 
Another commonly used method is to average data from right and left limbs. This becomes 
particularly problematic in rheumatic diseases that present with asymmetrical involvement, 
for example, osteoarthritis, gout and spondyloarthropathy, as averaging data may lessen the 
apparent magnitude of the disease and can lead to inaccurate inferences. Furthermore, 
without regarding the right and left sides as repeated within-subject measurements, 
efficiency and power are also lost. Similarly, averaging of repeated measurements is also 
common practice when measuring outcomes in quantitative research, whereby data is 
obtained over multiple trials (generally three) for each limb and their average used in 
subsequent analyses. Averaging is primarily undertaken to reduce measurement error; 
however, this method also removes useful information when the number of averaged trials 
may differ. Inefficiencies also arise when variables measured from multiple joints or regions 
within each limb are analysed separately without appropriately accounting for between-
region correlations [12]. 
The issue of between-limb dependence in statistical analysis has been identified in several 
research fields, including ophthalmology [13], podiatry [14, 15], orthopaedics [16] and 
rheumatology [17]. However, there is currently no consensus on the correct analytical 
approach of data collected from multiple trials from multiple limbs and/or regions within 
limbs. This article aims to compare three linear regression techniques, commonly used in 
current research under a generally incorrect assumption of independence between regions, 
with a mixed linear regression model that provides a more appropriate account for the 
association between limbs, regions, and trials, and that utilises all information available from 
repeated trials.  
 
METHODS 
Data set 
For the purpose of illustrating the various analysis methods in the current article, peak plantar 
pressure data, a continuous variable measured in kilopascals (kPa), was taken from a larger 
data set [18]. The aim of the original study was to compare the plantar pressure distribution 
during barefoot walking in people with gout (n = 25) or people with asymptomatic 
hyperuricaemia (n = 27) with that of healthy individuals with normal serum urate 
concentrations (n = 34). Plantar pressure data was collected for both right and left feet of 
each participant over three repeated walking trials. Peak plantar pressure was calculated for 
each of seven masked regions of the plantar foot representing the heel, midfoot, first 
metatarsal, second metatarsal, metatarsals three to four, the hallux and the lesser toes. For 
the full methodological protocol we direct readers to the original article [18].   
Statistical analysis 
Two comparisons were considered for all analytical approaches: gout vs. normouricaemic 
control and asymptomatic hyperuricaemic vs. normouricaemic control. Each analytical 
approach posited residual variances that differed at each of the seven masked regions of the 
plantar foot. Age and body mass index (BMI) were included in all analyses as covariates. To 
allow for systematic difference between left and right feet, a fixed effect for foot was added 
to Analysis Methods 2 and 4. The distribution of residuals for each linear model were 
examined to ensure demonstration of sufficient normality prior to undertaken the analyses. 
All hypothesis tests were carried out at a 5% level of significance against two-sided 
alternatives. All test statistics (least-squares means), their null distributions and their 
observed significance levels were reported. Data were analysed using SAS version 9.3. The 
data set was analysed using the following four approaches: 
Analysis Method 1: The peak plantar pressure data obtained from the right foot only was 
used. The mean of the three repeated trials was calculated for each right foot and was 
analysed using linear regression models, in which peak plantar pressure was the dependent 
variable and the diagnostic group and covariates were included as fixed effects. Each of the 
seven masked regions were analysed separately, resulting in the use of seven separate data 
sets.  
Analysis Method 2: The peak plantar pressure data obtained from a randomly selected left or 
the right foot from each participant was used. The mean of the three repeated trials was 
calculated for each randomly selected foot and was analysed using the linear regression 
technique described above in Analysis Method 1.  
Analysis Method 3: The mean peak plantar pressure values obtained over the three repeated 
walking trials were calculated for each participant’s right and left foot. The right and left foot 
data was then averaged for each participant, and the resulting value was analysed using the 
linear regression technique described above in Analysis Methods 1 and 2.  
Analysis Method 4: The single data set used by this method consisted of peak plantar pressure 
measurements for each trial, at all plantar masked regions, for both right and left feet. A 
mixed-effects linear regression model was used in which the fixed-effects of diagnostic group 
and covariates were nested within the plantar foot region variable. The diagnostic group and 
covariate effects were allowed to differ depending on the region. Repeated trial 
measurements taken from the right and left feet of each participant were accounted for using 
participant-specific random effects (fitting one parameter accounting for all covariances 
between measurements from different sides) and participant-nested random effects for foot 
side (fitting a distinct parameter accounting for all covariances between measurements from 
the same side and different trials). Additionally, the association between measures taken 
from the seven masked regions on the plantar foot, which form a natural vector of related 
variables, was taken into account by allowing a heterogeneous compound symmetry 
covariance structure on the model residuals that allowed for separate variances for each 
region, as well as different covariances (but equal correlations, conditionally on the random 
effects) between each pair of regions. This model can be described as a mixed effects linear 
model [1], with repeated measures of peak plantar pressure at the seven masked regions on 
each side as the dependent variable. 
It should be noted that it is possible to control for multiple testing [19] across the masked 
regions using any of the four Analytical Methods presented; to foster clarity and avoid 
controversy [20], we add no more on this topic. However only Analysis Method 4 allows a 
single general test of difference between diagnostic groups against a null of no difference in 
any of the regions. (The observed significance level of the region and diagnostic group 
interaction term is the p-value for this test.) One common practice is to carry out this general 
test, then delve into specific differences only if the alternative is accepted. Since we are 
proposing Analysis Method 4 as a candidate replacement for the other Analysis Methods, we 
emphasise estimation over testing in our presentation and eschew this practice. 
An anonymous referee has recommended use of the Kenward-Roger method to estimate 
denominator degrees of freedom for the computation of test statistics and standard errors, 
in line with current best statistical practice. The reader, as a result, will notice some slight 
discrepancies between the results published herein and the results published in [18], 
although none of the conclusions are at variance. 
SAS code for all Analysis Methods is provided in Supplementary File 1. 
Method comparison 
The criteria used to compare the four analysis methods consisted of the mean difference 
estimates and the width of the confidence intervals for the mean differences for each plantar 
foot region. Confidence interval widths for the mean differences provide a convenient proxy 
for statistical efficiency. Statistical efficiency, hereafter simply efficiency, is formally defined 
as one over the asymptotic (large-sample) variance of an estimator [21]. As such, an increase 
in efficiency translates into increased precision of an estimate (i.e. decreased confidence 
interval width), and increased power and smaller observed significance levels in hypothesis 
tests when the alternative is true.  Methods that increase statistical efficiency extract more 
information from any given set of data, and are therefore more statistically and scientifically 
appropriate. 
 
RESULTS 
Significant between-group differences were observed between gout and control participants, 
and asymptomatic hyperuricaemia and control participants, at only the midfoot from Analysis 
Methods 1 to 3 (Tables 1, 2, and 3, respectively). From Analysis Method 4, compared to 
controls, participants with gout had significantly reduced pressure at the heel and hallux and 
increased pressure at the midfoot, while participants with asymptomatic hyperuricemia had 
significantly increased pressure at the midfoot, first metatarsal and second metatarsal (Table 
4). Estimated mean differences in peak pressure between diagnostic groups (Figure 1A) were 
similar across all analysis methods, while the confidence interval widths for the mean 
differences were consistently smaller for Analysis Method 4 (Figure 1B). The mean peak 
pressure estimates for each diagnostic group were also similar across analysis methods 
(Figure 2A), while confidence interval widths were again consistently lowest from Analysis 
Method 4 (Figure 2B). 
 
DISCUSSION 
This analysis compared three statistical approaches commonly used in the assessment of 
musculoskeletal outcomes in rheumatic diseases to analyse data collected from multiple 
limbs, regions and trials by discarding or averaging data, with a model that accounts for the 
association between limbs, regions and trials, and that utilises all data from repeated trials.  
The results indicate that although all four methods produced similar mean peak pressure 
estimates, thereby demonstrating similar properties in regard to bias (in a statistical sense), 
the mixed effects linear model on non-averaged data consistently produced the narrowest 
confidence intervals for these parameters, when compared to the other three methods, and 
therefore demonstrated the greatest efficiency. This improved power and efficiency was 
achieved from utilising information present in the covariance between the areas of the feet, 
as well as the information present in each trial from both feet.   Although the method that 
averaged data from right and left feet resulted in a loss of efficiency when compared to the 
mixed-effects model, it demonstrated narrower confidence intervals when compared to the 
methods that utilised only right foot data, or data from a randomly selected right or left foot. 
This resulted from the utilisation of information from both feet in the process of averaging 
data, since averaging reduces variance. 
The loss of efficiency that occurs when independence between clusters (such as clusters of 
trials within region, regions within foot, or limbs within person) is assumed, can be large even 
for small to moderate correlations [22]. The mixed-effects model, which was designed along 
theoretical lines [22], enabled hitherto statistically nonsignificant between-group 
comparisons to be revealed as being actually statistically significant [18]. It is not uncommon 
for studies of low statistical power and sample size to demonstrate non-statistically significant 
results that are clinically important [23, 24].  
 
The mixed effects approach of Analysis Method 4 has a number of additional benefits. Firstly, 
utilisation of all data from both limbs means that all available information is retained. This is 
particularly important in rheumatic diseases such as osteoarthritis, gout and psoriatic 
arthritis, which have a tendency to monoarthropathy, meaning musculoskeletal pathology is 
commonly unilateral, especially in early disease stages. Secondly, Analysis Method 4 allows 
for analyses to be conducted using a single data set. This provides a more straightforward and 
time-friendly approach compared to running separate analyses for separate data sets as was 
undertaken in Analysis Methods 1 to 3. Thirdly, as it utilises data from both limbs without 
being labelled “double dipping” [15], it requires a smaller sample size than methods using 
single limb data, to achieve statistical power [25]. This has particular relevance to 
rheumatology research in which the vulnerability of potential participants often renders 
recruitment difficult. Fourthly, such models allow the introduction of individual limb- and 
region-specific covariates if desired, without difficulty, although we used no such covariates 
in the present work. Fifthly, another benefit in using a mixed effects linear model approach is 
that bias is reduced in fixed effect estimates in the presence of incomplete data, assuming 
that data are missing at random [1]. Finally, the mixed-effects approach has broad 
applicability and can extend both logistic and multinomial regression models in the case of 
binary and nominal dependent variables. 
This article should be considered in light of a number of limitations. Firstly, several criteria 
provide between-model comparisons (i.e. Information Criteria) [26], but due to the different 
processing of the repeated trials data (i.e. the trial averaging used in the first three models 
vs. the use of data from all trials for the mixed-effects model) and the different utilisation of 
left and right limb data, data sets differed and therefore, such criteria were not suitable to be 
used for comparison. That said, our purpose was not to look at prediction efficiency, which is 
optimised by some Information Criteria, but rather to look at the efficiency of estimation of 
means and mean differences between diagnostic groups, as provided by the confidence 
interval width measure. Secondly, the current article utilised SAS software to analyse the 
data, which may not be familiar to all researchers and may require researchers to seek 
additional statistical guidance. However, the syntax utilised in this article is provided as a 
Supplementary File to aid readers’ understanding.  
 
In conclusion, this article has shown how the adoption of a mixed linear regression model 
efficiently addresses the issue of between-limb dependence in musculoskeletal research 
through retaining individual side and trial data, and utilising the relationship between region 
measurements on the same foot. The improved efficiency and power generated from this 
model produces more precise estimates compared to alternative approaches that discard or 
average data, and which model region measurements independently. By adopting this 
method to analyse data collected from both right and left limbs, and from multiple regions 
within limbs, as well as across multiple trials, musculoskeletal rheumatology researchers 
would generate more clinically and statistically sound research outputs.  
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FIGURE LEGENDS 
 
Figure 1. Mean difference in peak pressure (kPa) between diagnostic groups for sites (A) and 
95% confidence interval widths for mean difference in peak pressure (kPa) between 
diagnostic groups for sites (B). 
 
Figure 2. Mean peak pressure (kPa) estimates for each diagnostic group for sites (A) and 
95% confidence interval widths for mean peak pressure (kPa) estimates for each diagnostic 
group for sites (B). 
 
 
  
   
   
 Table 1. Peak plantar pressure (kPa) using Analysis Method 1 (general linear regression analysing 
right foot data only) 
Parameter 
Least-
squares 
mean 
Diff. 
95% CI 
p Lower Upper 
Heel 
Control 274.3     
Gout 254.9 -19.5 -57.7 18.8 0.315 
Asymptomatic 
hyperuricemia 
298.8 24.5 -12.8 61.8 0.196 
Midfoot 
Control 97.4     
Gout 126.8 29.4 3.1 55.7 0.029 
Asymptomatic 
hyperuricemia 
126.5 29.1 3.5 54.7 0.027 
First metatarsal 
Control 216.0     
Gout 228.6 12.5 -31.4 56.5 0.571 
Asymptomatic 
hyperuricemia 
245.9 29.9 -12.9 72.7 0.168 
Second 
metatarsal 
Control 296.5     
Gout 309.1 12.6 -25.9 51.1 0.516 
Asymptomatic 
hyperuricemia 
320.2 23.7 -13.8 61.2 0.212 
Third to fifth 
metatarsals 
Control 258.1     
Gout 248.2 -9.9 -44.5 24.7 0.570 
Asymptomatic 
hyperuricemia 
248.9 -9.2 -42.9 24.6 0.591 
Hallux 
Control 223.0     
Gout 213.9 -9.1 -55.4 37.1 0.695 
Asymptomatic 
hyperuricemia 
246.5 23.5 -21.5 68.6 0.302 
Lesser toes 
Control 104.5     
Gout 127.0 22.4 -8.0 52.9 0.147 
Asymptomatic 
hyperuricemia 
108.9 4.4 -25.3 34.1 0.769 
Results are presented adjusted for age and BMI. Bolded P values indicate significant difference between groups at P < 
0.05. Diff. = Difference in least-squares mean from control group; CI = Confidence Interval. 
 
  
Table 2. Peak plantar pressure (kPa) using Analysis Method 2 (general linear regression analysing 
random left or right foot) 
Parameter 
Least-
squares 
mean 
Diff. 
95% CI 
p Lower Upper 
Heel 
Control 304.5     
Gout 269.2 -35.3 -72.3 1.7 0.061 
Asymptomatic 
hyperuricemia 
304.1 -0.4 -36.6 35.7 0.982 
Midfoot 
Control 84.2     
Gout 133.8 49.6 25.8 73.4 <0.001 
Asymptomatic 
hyperuricemia 
110.8 26.6 3.4 49.9 0.025 
First metatarsal 
Control 223.8     
Gout 242.5 18.7 -18.4 55.9 0.319 
Asymptomatic 
hyperuricemia 
241.7 17.9 -18.4 54.2 0.329 
Second 
metatarsal 
Control 280.9     
Gout 273.4 -7.5 -48.7 33.7 0.719 
Asymptomatic 
hyperuricemia 
324.4 43.5 3.2 83.8 0.035 
Third to fifth 
metatarsals 
Control 239.3     
Gout 225.4 -14.0 -48.2 20.3 0.419 
Asymptomatic 
hyperuricemia 
250.1 11.0 -22.7 44.2 0.524 
Hallux 
Control 244.8     
Gout 208.8 -36.0 -82.8 10.8 0.130 
Asymptomatic 
hyperuricemia 
244.4 -0.4 -46.1 45.3 0.986 
Lesser toes 
Control 101.9     
Gout 126.0 24.0 -3.5 51.6 0.086 
Asymptomatic 
hyperuricemia 
104.5 2.54 -24.4 29.4 0.851 
Results are presented adjusted for age and BMI. Bolded P values indicate significant difference between groups at P < 
0.05. Diff. = Difference in least-squares mean from control group; CI = Confidence Interval. 
 
 
 
 
 Table 3. Peak plantar pressure (kPa) using Analysis Method 3 (general linear regression using data 
averaged from right and left feet) 
Parameter 
Least-
squares 
mean 
Diff. 
95% CI 
p Lower Upper 
Heel 
Control 294.0     
Gout 270.0 -24.0 -60.0 11.9 0.188 
Asymptomatic 
hyperuricemia 
302.1 8.1 -27.0 43.2 0.647 
Midfoot 
Control 95.8     
Gout 131.2 35.4 14.0 56.7 0.002 
Asymptomatic 
hyperuricemia 
119.5 23.7 2.8 44.5 0.026 
First metatarsal 
Control 213.0     
Gout 229.0 16.0 -18.0 49.9 0.353 
Asymptomatic 
hyperuricemia 
238.5 25.5 -7.1 58.0 0.123 
Second 
metatarsal 
Control 293.0     
Gout 287.3 -5.6 -40.4 29.1 0.748 
Asymptomatic 
hyperuricemia 
321.4 28.4 -5.4 62.3 0.099 
Third to Fifth 
metatarsals 
Control 252.2     
Gout 243.2 -9.0 -39.0 21.0 0.551 
Asymptomatic 
hyperuricemia 
255.9 3.7 -25.5 32.9 0.802 
Hallux 
Control 232.4     
Gout 208.7 -23.7 -66.7 19.3 0.276 
Asymptomatic 
hyperuricemia 
242.5 10.1 -31.9 52.0 0.635 
Lesser toes 
Control 106.0     
Gout 121.3 15.3 -11.0 41.7 0.251 
Asymptomatic 
hyperuricemia 
107.7 1.7 -24.0 27.4 0.894 
Results are presented adjusted for age and BMI. Bolded P values indicate significant difference between groups at P < 
0.05. Diff. = Difference in least-squares mean from control group; CI = Confidence Interval. 
 
  
Table 4. Peak plantar pressure (kPa) using Analysis Method 4 (mixed linear regression with 
random effects to account for paired foot data and related plantar foot sites) 
Parameter 
Least-
squares 
mean 
Diff. 
95% CI 
p Lower Upper 
Heel 
Control 294.2     
Gout 268.2 -26.1 -46.5 -5.6 0.013 
Asymptomatic 
hyperuricemia 
302.0 7.7 -12.2 27.7 0.445 
Midfoot 
Control 95.4     
Gout 130.8 35.4 15.4 55.5 0.0006 
Asymptomatic 
hyperuricemia 
120.1 24.7 5.2 44.2 0.0134 
First metatarsal 
Control 211.5     
Gout 229.7 18.2 -5.2 41.6 0.126 
Asymptomatic 
hyperuricemia 
239.7 28.3 5.6 51.0 0.015 
Second metatarsal 
Control 292.6     
Gout 287.1 -5.5 -27.0 16.0 0.614 
Asymptomatic 
hyperuricemia 
321.4 28.8 7.8 49.7 0.007 
Third to fifth 
metatarsals 
Control 252.2     
Gout 244.1 -8.2 -29.6 13.3 0.455 
Asymptomatic 
hyperuricemia 
255.2 3.0 -18.0 23.9 0.780 
Hallux 
Control 233.2     
Gout 208.4 -24.8 -48.2 1.5 0.037 
Asymptomatic 
hyperuricemia 
241.9 8.7 -14.1 31.4 0.454 
Lesser toes 
Control 105.9     
Gout 121.8 15.9 -2.9 34.8 0.097 
Asymptomatic 
hyperuricemia 
107.2 1.4 -17.0 19.7 0.883 
Results are presented adjusted for age and BMI. Bolded P values indicate significant difference between groups at P < 
0.05. Diff. = Difference in least-squares mean from control group; CI = Confidence Interval. 
 
 
